A biotech startup born of an academic research project and inspired by emerging companies led…
dcorriganJune 17, 2022
Seattle Children’s Research Institute today announced the Invent at Seattle Children’s Postdoctoral Scholars Program, a $45…
dcorriganJune 16, 2022
An RNA-focused therapeutics company, Seattle-based Shape Therapeutics has developed a technology that is allowing it to…
dcorriganJune 15, 2022
Cancer clinical trials have long had a disparity problem, but a new push for more…
dcorriganJune 14, 2022
Ensuring good health for all is a tall order, and organizations within marginalized communities are…
dcorriganJune 14, 2022
Prolific biotech co-founder and University of Washington scientist David Baker, head of the UW Institute…
dcorriganJune 14, 2022
Umoja Biopharma, an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells to treat…
dcorriganJune 13, 2022
Phase Genomics, Inc., a leading developer of proximity ligation-based genomic solutions, today announced $5.5MM in…
pthomsonJune 13, 2022
The natural molecular vaccine adjuvant QS-21 is in increasing demand for several approved vaccines, including…
pthomsonJune 10, 2022
